Content
All Posts > Content under Healthcare
Choice And Health Insurance Coverage
Article By:
Timothy Taylor
Read
Monday, November 13, 2017 11:38 AM EDT
Government health spending (including federal, state, and local) does accounts for about 46% of total US health care spending.
Is Cardinal Health A Potential Buy
Article By:
Andreas Gruener
Read
Monday, November 13, 2017 10:54 AM EDT
Cardinal Health is another stock of the health sector which experienced a heavy decrease in its price in 2017. The total performance is -18.65%. The current share price is at 58.55 USD which offers you a yield of 3.06%.
CVR Medical: A New Approach To Cardiovascular Care
Article By:
Terry Chrisomalis
Read
Monday, November 13, 2017 10:17 AM EDT
CVR Medical's proprietary device could change the spectrum of stroke prevention and diagnostics.
In this article: CRRVF
Weighing The Week Ahead: The Millennial Effect On The Housing Market
Article By:
Jeff Miller
Read
Sunday, November 12, 2017 5:16 AM EDT
With several housing reports on tap, that may well be the focus of attention. So far, the recovery has been led by consumer spending, with little help from business investment or housing.
Pharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod
Article By:
Arpita Dutt
Read
Friday, November 10, 2017 3:13 PM EDT
Earnings remained in focus this week with companies like AstraZeneca reporting third-quarter results. Meanwhile, companies like Roche and Merck & Co., Inc. were in the news due to regulatory updates.
Dougherty’s Pharmacy, Inc. Reports Third Quarter 2017 Earnings
Article By:
NASDAQ GlobeNewswire
Read
Friday, November 10, 2017 12:48 PM EDT
Dougherty’s Pharmacy, Inc. today announced its results for the third quarter of fiscal 2017.
In this article: MYDP
Aurora Cannabis Continues To Grow Like A Weed
Article By:
Technical420
Read
Friday, November 10, 2017 7:21 AM EDT
Aurora Cannabis Inc. continues to execute and advance its business model as Canada prepares to legalize recreational cannabis and the market has taken notice of this.
Cannabis Stocks Break Out Of A Year Long Consolidation
Article By:
Justin Smyth
Read
Thursday, November 9, 2017 1:54 PM EDT
Three main cannabis stocks exploded higher on massive volume increases over the past couple of weeks. Not only that but their recent moves busted them out of a year-long consolidation in a very bullish manner.
ADMA Biologics Announces Pricing Of Follow-On Offering
Article By:
NASDAQ GlobeNewswire
Read
Thursday, November 9, 2017 11:27 AM EDT
ADMA Biologics, Inc. today announced the pricing of an underwritten public offering of approximately 17.0 million shares of its common stock at a public offering price of $2.15 per share, representing gross proceeds of approximately $36.5 million.
In this article: ADMA
AstraZeneca (AZN) Misses Q3 Earnings, Tweaks 2017 EPS View
Article By:
Zacks Investment Research
Read
Thursday, November 9, 2017 11:15 AM EDT
AstraZeneca plc reported third-quarter 2017 core earnings of 56 cents per American Depositary Share (ADS), which missed the Zacks Consensus Estimate of 57 cents.
Humana (HUM) Beats Q3 Earnings Estimates, Revenues Miss
Article By:
Zacks Investment Research
Read
Wednesday, November 8, 2017 1:55 PM EDT
Humana Inc.’s third-quarter 2017 operating earnings per share of $3.39 beat the Zacks Consensus Estimate by approximately 3.7%. The bottom line improved 6.6% year over year driven by lower share count.
Divine Davita
Article By:
Tim Knight
Read
Wednesday, November 8, 2017 12:20 PM EDT
Davita is down over 10% right now, and I think, given the completed topping pattern, it has plenty more potential downside.
In this article: DVA
Citius Pharma: Fast Track To Success
Article By:
Stone Fox Capital
Read
Wednesday, November 8, 2017 12:12 PM EDT
The small biotech offers a promising pipeline in therapies with unmet medical needs while trading under the radar of the market.
In this article: CTXR